EDIUNET Free equity investment tool of Japanese companies

Companies Cart
@
Financial Outline Report
Annual
First quarter
Second quarter
Third quarter
Sponsored Link
Related Company
@ NIHON NOHYAKU +
@ Kao +
@ ROHTO PHARMACEUTICAL +
@ 中外製薬 +
@ Fuso Pharmaceutical Industries +
@ DAIICHI SANKYO +
@ アステラス製薬 +
@ 持田製薬 +
@ 塩野義製薬 +
@ TSUMURA & CO. +
@ 富士製薬工業 +
@ Mitsubishi Tanabe Pharma +
@ エスケー化研 +
@ The Nippon Synthetic Chemical Industry +
@ JSR +
EDIUNET Related Ranking
EDIUNET
EDIUNET Credit Rating
EDIUNET Industry Avg
EDIUNET Prefectures
Yuho! Industry
EDIUNET Rating News
Prev « 2025-05 » Next
Mon Tue Wed Thu Fri Sat Sun
1
-
2
-
3
-
4
-
5
-
6
-
7
-
8
-
9
-
10
-
11
-
12
-
13
-
14
-
15
-
16
-
17
-
18
-
19
-
20
-
21
-
22
-
23
-
24
-
25
-
26
-
27
-
28
-
29
-
30
-
31
-
[Update list]
1/28 Retail Trade (CAWACHI:A etc...
1/27 Banks (The Awa Bank:BBB→A)
1/23 Chemicals (Milbon:AA→AAA)
1/21 Glass & Ceramics Products (..
1/21 Machinery (TSUDAKOMA:C)
1/21 Other Services (Netindex.:CC)
1/20 Other Products (Kurogane Kos..
1/20 Wholesale Trade (リーバイ・..
1/20 Other Services (川崎地質:BB→..
1/17 Chemicals (Kawaguchi Chemica..
 RSS
 Company RSS
 Daily RSS
Sponsored Link
Recently Download Chart
ROHM
graph
SANKEI CHEMICAL
graph
PIONEER
graph
日本セラミック etc.
graph
日本セラミック etc.
graph

Financial Outline Report: 中外製薬 (Annual )

It is a free Financial Outline Report which can grasp intuitively a financial statement summary , a corporate value, credit rating, etc. by various charts.Two or more companies can be compared and various charts can also be downloaded.

【Analysis Menu】 @Outline @Statement @Rating @Indicator @Download

Sponsored Link

Credit Rating (Bankruptcy Risk) Consolidated | Non-Consolidated

Date Credit Rating Comment Sales Current Profit Net Income
2012-12-31  AA  Credit is very high, slightly affected by biz environs. ¥ 391 B
4.73%
¥ 75 B
18.59%
¥ 48 B
36.81%

Financial Timeline

Date  2012-03-31 
(First quarter )
 2012-06-30 
(Second quarter )
 2012-09-30 
(Third quarter )
 2012-12-31 
(Annual )
Credit Rating AAAAAAAAAA
Total Assets
¥ 532 B
¥ 542 B
¥ 544 B
¥ 587 B
Net Assets
¥ 460 B
¥ 469 B
¥ 467 B
¥ 490 B
Net Assets have increased 4consecutive terms. The fiscal base is getting better.
Cash(¥ 110 B) is more than the total liabilities(¥ 97 B). It is a very steady fiscal base!

Financial Chart Download


Financial Statement Details

Financial Indicator Details

Sponsored Link


Related Company

@ 塩野義製薬 (Sales ¥ 282 B) +
@ ダイセル (Sales ¥ 358 B) +
@ HISAMITSU PHARMACEUTICAL (Sales ¥ 142 B) +
@ Kuraray (Sales ¥ 369 B) +
@ エスケー化研 (Sales ¥ 82 B) +
@ Nihon Parkrizing (Sales ¥ 89 B) +
@ JSR (Sales ¥ 371 B) +
@ NIPPON PAINT (Sales ¥ 233 B) +
@ 大正製薬ホールディングス (Sales ¥ 285 B) +
@ Mitsubishi Tanabe Pharma (Sales ¥ 419 B) +
@ Fuso Pharmaceutical Industries (Sales ¥ 48 B) +
@ 持田製薬 (Sales ¥ 89 B) +
@ アステラス製薬 (Sales ¥ 1.0 T) +

関連する株式投資情報

EDIUNET Caution

*Financial data might be different from the actual one. Please confirm the original, and read Caution.

*This site has obtained the information from the FSA's EDINET, Tokyo Stock Exchange's TDnet and Pay statistical data services, Fukuoka stock Exchange's Stock market capitalization, Center for Spatial Information Science's CSV Geocoding Service. The copyright of the information belongs to each corporation etc. .

▲ Go to the top ▲

  • @Company Search
    • [close]
      [keyword]

      Company Search
      *It can search to each item of a type of industry, a stock market, the settlement-of-accounts moon, and a keyword.
      *Top 30 search results are displayed.
      [close]
  1. Guide
  2. Mobile
  3. Tablet
  4. Japanese
`EDIUNET` Copyright©2006-2025 `MAバンク` (0.097 sec.)